Buprenorphine: new tricks with an old molecule for pain management.
about
Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.Prescription opioid abuse, pain and addiction: clinical issues and implicationsThe subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone.Opioids and the treatment of chronic pain: controversies, current status, and future directions.Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic.Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol.Sublingual buprenorphine for chronic pain: a survey of clinician prescribing practices.Activity of new NOP receptor ligands in a rat peripheral mononeuropathy model: potentiation of morphine anti-allodynic activity by NOP receptor antagonists.Recent advances in the pharmaceutical management of pain.Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.Sublingual buprenorphine as an analgesic in chronic pain: a systematic review.Buprenorphine for cancer pain: is it ready for prime time?An observational study of buprenorphine treatment of the prescription opioid dependent pain patient.2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.Recent development in therapeutics for breakthrough pain.Perioperative management of a patient undergoing Clagett window closure stabilized on Suboxone® for chronic pain: a case report.Dose-Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects.
P2860
Q33751060-E2232879-61C5-47B5-A914-5E86DB504F8BQ34223553-8D6783A6-B36D-4CE4-8742-4B0DEDD2883BQ34661770-C8EF23EC-2831-43E6-925A-B8C05F2AEBE0Q34846394-682B5B52-758E-43B1-AE97-8C4EFCB42A53Q36513547-2CCBFBE1-9ECF-47B8-A82A-0C0C8FF03975Q36779246-2F8218EC-CBB8-423B-8CEB-4DF631E1AECEQ37251600-DE3539CC-EBF1-4BDA-826F-686FBE93293BQ37343674-999A8D7A-D82B-4B2A-A654-FFB30BC2D0E7Q37960192-AB949C2B-3D55-4274-A674-174F2DA1BB3EQ38093852-8ADA40E8-12F1-433B-8B1A-DE85AF48552EQ38226336-ABCE0017-2439-4B7B-BD5B-A818595475A9Q38243938-6CFAB78A-2FA2-4864-833F-66DC3D36B4C4Q41444560-3CFF4297-C493-4501-AC8E-F9516255CE8EQ41919082-150B302B-FBFD-4599-BC52-9A5AE0665B82Q43085276-739DE92B-168D-489F-8CC1-22466DE429F5Q47849102-9182ECBA-EC02-467B-A1DE-3ECE534BB5F7Q51529259-204F9291-C858-4B32-A36D-ACDBEDA23283
P2860
Buprenorphine: new tricks with an old molecule for pain management.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Buprenorphine: new tricks with an old molecule for pain management.
@en
Buprenorphine: new tricks with an old molecule for pain management.
@nl
type
label
Buprenorphine: new tricks with an old molecule for pain management.
@en
Buprenorphine: new tricks with an old molecule for pain management.
@nl
prefLabel
Buprenorphine: new tricks with an old molecule for pain management.
@en
Buprenorphine: new tricks with an old molecule for pain management.
@nl
P1476
Buprenorphine: new tricks with an old molecule for pain management.
@en
P2093
Douglas L Gourlay
Howard A Heit
P356
10.1097/AJP.0B013E31815CA2B4
P407
P577
2008-02-01T00:00:00Z